NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $215,000 | -4.9% | 65,555 | 0.0% | 0.03% | -11.4% |
| Q3 2015 | $226,000 | +156.8% | 65,555 | -0.6% | 0.04% | +250.0% |
| Q2 2015 | $88,000 | +225.9% | 65,955 | -0.8% | 0.01% | +150.0% |
| Q4 2014 | $27,000 | -91.0% | 66,455 | -4.0% | 0.00% | -91.5% |
| Q3 2014 | $301,000 | -5.9% | 69,250 | +7.1% | 0.05% | -4.1% |
| Q2 2014 | $320,000 | -7.5% | 64,662 | +2.1% | 0.05% | -10.9% |
| Q1 2014 | $346,000 | -9.9% | 63,350 | 0.0% | 0.06% | -12.7% |
| Q4 2013 | $384,000 | -2.0% | 63,350 | +6.7% | 0.06% | -16.0% |
| Q3 2013 | $392,000 | +26.0% | 59,350 | -3.3% | 0.08% | +31.6% |
| Q2 2013 | $311,000 | – | 61,350 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 41,650 | $253,000 | 0.18% |
| Eidelman Virant Capital | 27,796 | $169,000 | 0.07% |
| WMS Partners, LLC | 63,350 | $384,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $381,000 | 0.05% |
| Brown Advisory Securities, LLC | 10,000 | $61,000 | 0.02% |
| CROFT-LEOMINSTER INC | 20,000 | $121,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 15,479 | $94,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $152,000 | 0.01% |
| CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $734,000 | 0.00% |
| Virtu KCG Holdings LLC | 23,325 | $140,000 | 0.00% |